Close

Genome Valley emerges as Indias Top Life Sciences Cluster

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Pharmacy’s Impact on Reducing Medication Errors in Hospital Settings

Medication errors are a big problem in healthcare because...

How to Dispose of Pharmaceutical Waste

Proper pharmaceutical waste disposal is crucial for protecting our...

Semaglutide 101: What You Need to Know About This Game-Changing Medication

In the realm of modern medicine, breakthroughs are not...

Health Benefits of Pre-work Supplements

Whether you are a workout expert or just starting...

World Pharma Today / News / India – Genome Valley, Hyderabad by shipping one-third of the world’s vaccine demand among children has beaten Chennai and Bengaluru to become India’s top life sciences cluster. It is considered by many as Asia’s answer to the Boston Life Sciences Corridor, the US cluster which happens to be largest globally. Driving this massive supply of vaccines here are Pharma majors such as Bharat Biotech, Shantha Biotechnics, Indian Immunologicals Limited, and Biological E and many more. Vaccines supplied from here include Tetanus-Diphtheria (combination), Pentavalent, Japanese Encephalitis, Rotavirus, Typhoid Conjugate, and Hepatitis B&C.

This cluster is located at around 60 kms. from the city and houses 200 major firms that have more than 10000 employees working. India contributes 70% of the world’s vaccine market. There has been a significant amount of investment which Genome Valley has been able to draw in the last three years. The investment hovers between 6000-6500 crores which is massive. Besides, there are many top-end brands from Switzerland, Canada, and India that are making their way into the cluster.

Latest stories